Switch to:
More From Other Websites
Sarepta Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : SRPT-US :... Jan 23 2017
Catabasis Pharma surges 17% on positive early-stage clinical trial results for DMD drug Jan 19 2017
Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential Jan 19 2017
FDA 101: What Does 'Orphan Drug Designation' Mean? Jan 17 2017
Here's a New List of Stocks That Show Bullish or Bearish Reversal Patterns Jan 17 2017
Bullish and Bearish Reversals in the Market Jan 17 2017
Surge From Bank Earnings Doesn't Last Jan 13 2017
Sarepta Therapeutics, Inc. – Value Analysis (NASDAQ:SRPT) : January 12, 2017 Jan 12 2017
Sarepta Therapeutics Inc (SRPT) Gets Off To A Running Start With Eteplirsen Jan 11 2017
Sarepta Therapeutics: Reports of Its Demise Appear 'Greatly Exaggerated' Jan 11 2017
Sarepta Muscular Dystrophy Drug Posts Solid Sales Jan 11 2017
Latest Reports on Sarepta Therapeutics and Cempra as the NASDAQ Continues to Hit Record Highs Jan 11 2017
7 Stocks Making Big Moves With Unusual Volume Jan 11 2017
Are Options Traders Betting on a Big Move in Sarepta Therapeutics (SRPT) Stock? Jan 11 2017
Sarepta Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : SRPT-US :... Jan 11 2017
Tuesday’s Top Biopharma Movers Jan 10 2017
Sarepta gains $300M in value as Duchenne drug launch beats expectations Jan 10 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK